 |
It would be appropriate to try doing a trial of IGF-1 BP3
(Iplex) at a
higher dose. As ALS patients, many of us do not have two years
to waste on
stupidity. I used Iplex briefly before the lawsuit rendered it
unavailable. My "anecdotal" evidence supported slight improvement
in a short period of
time. Worth a shot when it comes to people waiting to die,
isn't it?
View all comments by Deborah Gattoni
|
 |